Table 3 Daily use of crystalloids, colloids and blood products depending on RBC transfusion on consecutive days of septic shock

Number of patients (%)

34 (16)

179 (84)

-

RBCs (ml)

490 (300-735)

-

-

Crystalloids and colloids (ml)

3000 (1800-4600), n = 31

3000 (1600-5000), n = 165

0.62

Platelets (ml)

350 (300-370), n = 7

350 (350-1050), n = 11

0.009

Fresh frozen plasma (ml)

550 (540-1080), n = 13

545 (531-600), n = 24

0.0004

Day 2

Number of patients (%)

32 (17)

156 (83)

-

RBCs (ml)

490 (245-490)

-

-

Crystalloids and colloids (ml)

2000 (1250-3000), n = 29

1650 (1000-3000), n = 129

0.22

Platelets (ml)

550 (420-980), n = 4

700 (350-1050), n = 13

0.49

Fresh frozen plasma (ml)

1050 (540-1200), n = 5

600 (540-1067), n = 16

0.37

Day 3

Number of patients (%)

31 (24)

98 (76)

-

RBCs (ml)

245 (245-490)

-

-

Crystalloids and colloids (ml)

1325 (800-2400), n = 22

1400 (900-2000), n = 71

0.91

Platelets (ml)

350 (350-1050), n = 8

350 (350-1050), n = 5

0.001

Fresh frozen plasma (ml)

540 (408-680), n = 8

540 (540-813), n = 11

0.06

Day 4

Number of patients (%)

17 (17)

82 (83)

-

RBCs (ml)

245 (245-245)

-

-

Crystalloids and colloids (ml)

1500 (1000-2000), n = 9

1000 (500-1300), n = 41

0.40

Platelets (ml)

700 (525-1050), n = 4

350 (300-700), n = 10

0.18

Fresh frozen plasma (ml)

405 (270-540), n = 2

560 (540-600), n = 10

0.88

Day 5

Number of patients (%)

18 (24)

58 (76)

-

RBCs (ml)

245 (245-490)

-

-

Crystalloids and colloids (ml)

500 (200-1100), n = 14

1000 (900-2000), n = 37

0.45

Platelets (ml)

350 (350-700), n = 5

1050, n = 1

0.0009*

Fresh frozen plasma (ml)

n = 0

537 (524-550), n = 2

0.44